BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28.11.2017

Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology; Public Workshop

The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology." The purpose of the public workshop is to engage stakeholders and solicit input from experts in oncology precision medicine on how to best weigh and evaluate evidence for classification and interpretation of sequencing results for precision oncology.

Source: Federal Register — Food and Drug AdministrationOpen original release →